Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 percent. This is a 20.45 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $5.401 billion which missed the analyst consensus estimate of $5.720 billion by 5.58 percent. This is a 5.22 percent increase over sales of $5.133 billion the same period last year.